The CODMAN® CERTAS™ THERAPY MANAGEMENT SYSTEM™ is used to read and adjust the valve setting in an outpatient setting. The Valve and Therapy Management System has been designed so a physician can easily read and adjust pressure settings non-invasively to meet the unique needs of patients.
Excessive accumulation of CSF results in the widening of the brain's ventricles, which can put harmful pressure on the brain. In infants, this may lead to an unusually large head size and produce symptoms including vomiting, sleepiness, irritability, downward deviation of the eyes and seizures.(2) More than 70 percent of hydrocephalus occurs during pregnancy or shortly after birth, as a result of a birth defect.(3)
Acquired hydrocephalus, which occurs later in life, may be caused by a blockage to the flow of CSF, a brain tumor or cyst, bleeding inside the brain, head trauma or infection. In adults 55 and older, it may cause normal pressure hydrocephalus (NPH), a little-known neurological condition characterized by three primary symptoms: cognitive decline and confusion, walking and balance problems and incontinence. Experts estimate about 375,000 people in the U.S. may have NPH.(4)
The most common treatment for hydrocephalus is the surgical implantation of a shunt, a flexible tube placed into the brain to divert excess CSF into another region of the body, most often the abdominal cavity. CSF is an essential bodily fluid produced continuously to cushion the brain and spinal cord tissue from injury and maintain a proper balance of nutrients around the central nervous system.
Codman has been a leading supporter of patient and professional education and advocacy for hydroceph
|SOURCE Codman & Shurtleff, Inc.|
Copyright©2010 PR Newswire.
All rights reserved